Nov 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Beauty Health, Design Therapeutics and Energizer Holdings, on Wednesday.
HIGHLIGHTS
* Beauty Health Co : Jefferies cuts to hold from buy
* Design Therapeutics Inc : Piper Sandler cuts to neutral from overweight
* Energizer Holdings Inc : JP Morgan cuts to underweight from neutral
* Fluent Inc : Canaccord Genuity cuts to hold from buy
* Spectaire Holdings Inc : Jefferies initiates coverage with hold rating
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* 2Seventy Bio Inc : Wedbush cuts target price to $4 from $7
* Abercrombie & Fitch Co : Citigroup raises price target to $75 from $58
* Advent Technologies Holdings Inc : Jefferies cuts PT to $0.45 from $0.6
* Aecom : Citigroup raises price target to $106 from $93
* Altria Group Inc : Jefferies cuts target price to $50 from $56
* American Eagle Outfitters Inc : Citigroup raises PT to $19 from $18
* $Aramark(ARMK-W)$ : Jefferies raises target price to $30 from $29
* Bakkt Holdings Inc : Jefferies cuts target price to $1 from $1.5
* Beauty Health Co : Jefferies cuts target price to $1.5 from $11
* Beauty Health Co : Jefferies cuts to hold from buy
* Biohaven Ltd : Leerink Partners raises target price to $31 from $28
* Biohaven Ltd : TD Cowen raises target price to $35 from $25
* Bioxcel Therapeutics Inc : Canaccord Genuity cuts PT to $18 from $20
* Boston Properties Inc : Citigroup cuts price target to $58 from $66
* Celanese Corp : Jefferies raises target price to $135 from $125
* Celanese Corp : JP Morgan raises target price to $125 from $122
* Cormedix Inc : RBC raises target price to $10 from $6
* Design Therapeutics Inc : Leerink Partners cuts target price to $4 from $6
* Design Therapeutics Inc : Piper Sandler cuts target price to $6 from $42
* Design Therapeutics Inc : Piper Sandler cuts to neutral from overweight
* Devon Energy Corp : RBC cuts target price to $55 from $60
* Dick's Sporting Goods Inc : Citigroup cuts price target to $112 from $118
* Energizer Holdings Inc : Canaccord Genuity raises target price to $36 from $34
* Energizer Holdings Inc : JP Morgan cuts to underweight from neutral
* Fathom Digital Manufacturing Corp : Craig-Hallum cuts PT to $5 from $15
* Fathom Digital Manufacturing Corp : Needham cuts target price to $8 from $20
* First Horizon Corp : RBC raises target price to $14 from $13
* Fiscalnote Holdings Inc : D.A. Davidson cuts target price to $0.65 from $2.75
* Fluent Inc : Canaccord Genuity cuts target price to $2 from $3
* Fluent Inc : Canaccord Genuity cuts to hold from buy
* Guidewire Software Inc : BTIG raises target price to $110 from $90
* Hippo Holdings Inc : KBW cuts target price to $16 from $19
* Home Depot Inc : Jefferies cuts target price to $365 from $384
* Home Depot Inc : JP Morgan cuts target price to $318 from $332
* Home Depot Inc : Piper Sandler raises target price to $311 from $302
* Home Depot Inc : RBC cuts target price to $299 from $303
* Home Depot Inc : Wedbush cuts target price to $330 from $350
* Hudson Pacific Properties Inc : Citigroup raises price target to $6 from $5.5
* Iheartmedia Inc : Goldman Sachs cuts target price to $2 from $3
* Jack In the Box Inc : Citigroup cuts price target to $80 from $103
* Kezar Life Sciences Inc : Jefferies cuts target price to $13 from $15
* Lifestance Health Group Inc : Jefferies cuts target price to $8 from $9
* Lucid Diagnostics Inc : Needham cuts target price to $2.5 from $2.8
* Mustang Bio Inc : BTIG cuts target price to $8 from $16
* Nordstrom Inc : Citigroup cuts price target to $14 from $18
* Perspective Therapeutics Inc : Jonestrading initiates coverage with buy rating
* Perspective Therapeutics Inc : Jonestrading initiates coverage with PT $1.4
* Philip Morris International Inc : Jefferies cuts PT to $104 from $105
* Plains All American Pipeline LP : Citigroup raises PT to $16.5 from $15.5
* Plains GP Holdings LP : Citigroup raises price target to $16.5 from $15.5
* Premier Inc : Baird cuts target price to $23 from $24
* Prokidney Corp : BTIG cuts target price to $6 from $16
* Q2 Holdings Inc : Citigroup raises price target to $42 from $39
* Sab Biotherapeutics Inc : H.C. Wainwright cuts target price to $1 from $2
* Sally Beauty Holdings Inc : Jefferies cuts target price to $8.5 from $9
* Silicon Laboratories Inc : Citigroup cuts price target to $112 from $148
* Snap Inc : Jefferies raises target price to $12 from $11
* Spectaire Holdings Inc : Jefferies initiates coverage with hold rating
* Spectaire Holdings Inc : Jefferies initiates coverage with PT $2.5
* Sutro Biopharma Inc : Piper Sandler cuts target price to $12 from $18
* Taysha Gene Therapies Inc : Baird cuts target price to $7 from $8
* Terns Pharmaceuticals Inc : JP Morgan cuts target price to $10 from $11
* Vivid Seats Inc : Citigroup raises price target to $12 from $11
* Workhorse Group Inc : BTIG cuts to neutral from buy
* Workhorse Group Inc : TD Cowen cuts target price to $0.5 from $1.5
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
